Identification of drug in pharmaceutical formulation by thin layer chrmotography
By: Sethi, P. D.
Contributor(s): Charegankar, Dilip.
Publisher: New Delhi CBS Publishers & Distributers 1999Edition: 2nd.Description: 253, 25*18.8 Pages | Binding - Paperback |.ISBN: 81-239-0635-8.Subject(s): PHARMACEUTICAL ANALYSISDDC classification: 615.1901 Online resources: Click here to access online Summary: TLC is to identify the unknown or to confirm the identity of the analyte. It can serve as a screening step followed by HPLC confirmation and quantitation resulting in lower analytical time and cost. The revised text describes procedures for separation detection and identification of each component in 1.72 divergent? multi-component pharmaceutical formulations using both normal and R.P. layers. Most of the formulations contain several alternate mobile phases for analysts to choose from and to optimise. The revised edition contains a comprehensive chapter on detection! Visualization reagents commonly used for post-chromatographic derivatization. Each reagent contains a list of common drugs which can be detected with the reagent.Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|---|
Text Books | School of Pharmacy Reference Section | Reference | 547.8 SET/CHA (Browse shelf) | Not For Loan | B0749 |
Browsing School of Pharmacy Shelves , Shelving location: Reference Section , Collection code: Reference Close shelf browser
547.59 LI Name reaction in heterocyclic chemistry | 547.59 PAr/PAR Essence of heterocyclic chemistry | 547.7 LED Steroid chemistry at a glance | 547.8 SET/CHA Identification of drug in pharmaceutical formulation by thin layer chrmotography | 571.293 ROS Chemical microbiology | 571.3 DAS Textbook of remedial biology | 571.3 GOK/KUL Remedial biology |
TLC is to identify the unknown or to confirm the identity of the analyte. It can serve as a screening step followed by HPLC confirmation and quantitation resulting in lower analytical time and cost. The revised text describes procedures for separation detection and identification of each component in 1.72 divergent? multi-component pharmaceutical formulations using both normal and R.P. layers. Most of the formulations contain several alternate mobile phases for analysts to choose from and to optimise. The revised edition contains a comprehensive chapter on detection! Visualization reagents commonly used for post-chromatographic derivatization. Each reagent contains a list of common drugs which can be detected with the reagent.
There are no comments for this item.